A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CR / clinical recurrence

[Related PubMed/MEDLINE]
Total Number of Papers: 30
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CR  (>> Co-occurring Abbreviation)
Long Form:   clinical recurrence
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study. HT, PSA, RP, RT, SRT
2019 Changes on Midchemoradiation Therapy Fluorodeoxyglucose Positron Emission Tomography for Cervical Cancer Are Associated with Prognosis. CI, CRT, DFS, DM, HR, NR, OS, TLG
2019 Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer. BCR, CI, HR, PCa, PSMs, RP
2019 Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy. ICEs, OS, SRT
2019 Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer. BCR, CI, HR, ICEs, OS, RP
2019 Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis. eCR, HR, PET/CT, PSA, RP, SLND
2019 Safety and Early Oncologic Outcomes of Lung Resection in Patients with Isolated Pulmonary Recurrent Prostate Cancer: A Single-center Experience. PC, RP
2019 Which Patients with Clinically Node-positive Prostate Cancer Should Be Considered for Radical Prostatectomy as Part of Multimodal Treatment? The Impact of Nodal Burden on Long-term Outcomes. PCa, RP
2018 More Extensive Lymph Node Dissection at Radical Prostatectomy is Associated with Improved Outcomes with Salvage Radiotherapy for Rising Prostate-specific Antigen After Surgery: A Long-term, Multi-institutional Analysis. CI, HR, LND, PSA, RP, SRT
10  2018 Predictive factors and the important role of detectable prostate-specific antigen for detection of clinical recurrence and cancer-specific mortality following robot-assisted radical prostatectomy. ADT, CSM, PSA, RARP
11  2018 The 17-Gene Genomic Prostate Score Assay Predicts Outcome After Radical Prostatectomy Independent of PTEN Status. BCR, FISH, GPS, IHC, PCa, PSA, PTEN, RP
12  2017 Are all grade group 4 prostate cancers created equal? Implications for the applicability of the novel grade grouping. BCR, PCa
13  2017 Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: Can surgery be postponed safely? BCR, PCa, RP
14  2017 Genomic Classifier Augments the Role of Pathological Features in Identifying Optimal Candidates for Adjuvant Radiation Therapy in Patients With Prostate Cancer: Development and Internal Validation of a Multivariable Prognostic Model. ART
15  2017 Post-operative recurrence of Crohn's disease after definitive stoma: an underestimated risk. APL, CD, DS, SR
16  2017 Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease. ER, POMP, RS
17  2017 Salvage lymph node dissection after 68Ga-PSMA or 18F-FEC PET/CT for nodal recurrence in prostate cancer patients. 18F-FEC, BCR, BR, cBR, CSS, LNs, PET/CT, PSA, SLND
18  2017 The New Prostate Cancer Grading System Does Not Improve Prediction of Clinical Recurrence After Radical Prostatectomy: Results of a Large, Two-Center Validation Study. BCR, C-index, GG, PCa, RP
19  2017 The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer. ADT, BCR, BR, cBR, LN, PCa, PET/CT, PT, RP, RT, sLND
20  2016 The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients. ADT, BR, CI, CSM, ePLND, HR, LNI, PSA, RP
21  2016 When Should a Positive Surgical Margin Ring a Bell? An Analysis of a Multi-Institutional Robot-Assisted Laparoscopic Radical Prostatectomy Database. PSA, SM
22  2015 eNOS3 Genetic Polymorphism Is Related to Post-Ablation Early Recurrence of Atrial Fibrillation. AF, ERAF, RFCA
23  2015 Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients. BCR, GS, PCa, PSA, RARP, RGs
24  2015 Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years. BCR, BR, CSM, LND, PCa, PET/CT, PSA, RP
25  2015 Patterns of Clinical Recurrence of Node-positive Prostate Cancer and Impact on Long-term Survival. BCR, CSM, PCa, RP
26  2014 Addition of mesalazine for subclinical post-surgical endoscopic recurrence of Crohn's disease despite preventive thiopurine therapy: A case-control study. CD, ER
27  2014 Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era. BCR, CI, HR, PSA
28  2011 Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography. BCR, BR, HR, LND, PET/CT, PSA, RP
29  2008 Restenosis begets restenosis: implications for stent selection. PCI
30  2000 [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease]. CD, MR, SR